Skip to main content
. Author manuscript; available in PMC: 2017 Mar 1.
Published in final edited form as: Clin Lung Cancer. 2015 Oct 23;17(2):113–118.e2. doi: 10.1016/j.cllc.2015.09.003

Table 5.

Multivariate Analysis: Baseline Variables and Overall Survival from 8-week Landmark, patients with complete data at baseline (N=191)

Parameter HR 95% CI p-value
Disease control rate 0.50 0.36 0.70 <.0001
Platinum Refractory 1.33 0.96 1.84 0.09
Age ≥ 65 0.99 0.71 1.38 0.94
Performance Status = 1 1.39 1.00 1.94 0.05
Current Smoker vs. (Former or Never) 1.00 0.71 1.40 0.98
Male Sex 1.16 0.83 1.61 0.38
Elevated LDH 1.38 0.98 1.94 0.06
2 or more prior chemotherapy regimens vs. only 1 0.58 0.29 1.17 0.13
Weight Loss ≥ 5% 1.11 0.75 1.63 0.61
Prior radiation therapy 0.78 0.54 1.13 0.18
S0802 vs. (S0435 or S0327) 1.03 0.71 1.50 0.88